CLDN1 and colitis: Additionally, in mice with DSS-induced colitis, syringic acid at doses of 25 and 50 mg/kg prevented colon damage, alleviated proptosis, and increased the mRNA expression of intestinal barrier proteins (claudin-1, ZO-1, and occludin) [28,29].